文献速递糖尿病

血浆微小RNA与青少年2型糖尿病治疗失败的相关性:TODAY研究

Plasma miRNAs and Treatment Failure in Participants in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
PubMed 文献 · Diabetes Care · 2024-01-01

在TODAY研究209名青少年2型糖尿病参与者中,评估血浆微小RNA组合能否预测治疗失败。结果显示miRNA组合不能预测治疗失败,但miR-4306每翻倍与失败风险降低12%相关(P=0.040),miR-483-3p每翻倍与失败风险增加12%边缘相关(P=0.080);两者联合可改善模型拟合(P=0.040)。

要点

  • miRNA组合未能预测青少年2型糖尿病治疗失败。
  • miR-4306每翻倍与治疗失败风险降低12%独立相关(P=0.040)。
  • miR-483-3p每翻倍与治疗失败风险增加12%边缘相关(P=0.080)。

核心结论

  • miR-483-3p和miR-4306可能与青少年2型糖尿病治疗失败相关。

研究设计与样本

  • 在TODAY研究参与者中(N=209),于训练/测试数据集中检验一组miRNA能否预测治疗失败,并分析单个miRNA与治疗失败的相关性。

主要发现

  • 参与者年龄14.5岁,62%为女性。
  • miRNA组合未能预测治疗失败。
  • 在校正性别、种族/族裔、BMI、Tanner分期、HbA1c、母亲糖尿病、口服处置指数和治疗分组后,miR-4306每翻倍与治疗失败降低12%相关(P=0.040)。
  • miR-483-3p每翻倍与治疗失败增加12%边缘相关(P=0.080)。
  • 联合加入两种miRNA改善模型拟合(无miRNA vs 有miRNA的对数似然 -360.3 vs -363.5;P=0.040)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify plasma miRNAs related to treatment failure in youth with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We examined whether a panel of miRNAs could predict treatment failure in training/test data sets among participants in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study (N = 209). We also examined whether individual miRNAs were associated with treatment failure. RESULTS: Participants were age 14.5 years, and 62% were female. A panel of miRNAs did not predict treatment failure. However, for each doubling, miR-4306 was associated with a 12% decrease (P = 0.040) and miR-483-3p was marginally associated with a 12% increase (P = 0.080) in failure independently of sex, race/ethnicity, BMI, Tanner stage, HbA1c, maternal diabetes, oral disposition index, and treatment arm. The addition of both miRNAs improved model fit (log likelihood without vs. with miRNAs -360.3 vs. -363.5; P = 0.040). CONCLUSIONS: miR-483-3p and miR-4306 may be associated with treatment failure in youth with T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wander PL, Bammler TK, MacDonald JW, et al. Plasma miRNAs and Treatment Failure in Participants in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2024. PMID: 38153877. doi:10.2337/dc23-1540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。